The role of the newer beta-lactam antibiotics in the treatment of infection in compromised hosts.
D000380:Agranulocytosis / Q000150:complications*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D009369:Neoplasms / Q000150:complications*; D009503:Neutropenia / Q000150:complications*; D018805:Sepsis / Q000188:drug therapy; D047090:beta-Lactams
D000900:Anti-Bacterial Agents; D047090:beta-Lactams